Sarah Untch

Sarah Untch, M.S., ACRP-CP has a diverse work experience in the field of clinical research. Sarah is currently the Director of Trial Operations at the Global Coalition for Adaptive Research, overseeing global operations for GBM AGILE, a phase II/III trial for patients with glioblastoma. Prior to this, they worked as an Associate Director of Trial Operations at the same organization.

Before joining the Global Coalition for Adaptive Research, Sarah worked at Agendia as the Director of Clinical Research, where they were responsible for strategic planning and operations of research. Sarah also served as a Clinical Research Manager, leading a team and overseeing multiple protocols. Earlier, as a Senior Clinical Research Associate and Clinical Research Associate at Agendia, they managed sites, reviewed data for quality, and conducted monitoring visits.

Sarah began their career at Precision Therapeutics as a Clinical Research Associate, focusing on site start-up and monitoring visits. Before that, they worked as a Clinical Trials Assistant where they gained experience and eventually transitioned to the role of a Clinical Research Associate.

Sarah started their research career as a Research Assistant at Rutgers University, where they worked in health psychology and neuroscience research projects.

Overall, Sarah Untch has extensive experience in trial operations, clinical research management, site monitoring, and strategic planning for various organizations in the healthcare industry.

Sarah Untch, M.S., ACRP-CP has a Master's degree in Clinical Research Organization and Management from Drexel University College of Medicine. Sarah also holds a Bachelor's degree from Rutgers University, with a major in Biotechnology, Biochemistry, and Psychology. In addition, Sarah has obtained the ACRP-CP certification from the Association of Clinical Research Professionals in March 2019.